These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6119922)

  • 1. Anxiolytics and beta blockers: evaluation of pharmacodynamics by quantitative EEG, psychometric and physiological variables.
    Saletu B; Grünberger J; Linzmayer L; Flener R
    Agressologie; 1981 Oct; 22(C):5-16. PubMed ID: 6119922
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationships of beta-blockers and anxiolytics intake and salivary secretion, masticatory performance and taste perception.
    de Matos LF; Pereira SM; Kaminagakura E; Marques LS; Pereira CV; van der Bilt A; Pereira LJ
    Arch Oral Biol; 2010 Feb; 55(2):164-9. PubMed ID: 20018274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical review of beta-blockers in anxiety.
    Kelly D
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Sep; 13(5):259-66. PubMed ID: 6108580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta blockers as agents against anxiety. Therapeutic results, physiological mechanism and philosophical considerations].
    Naess K
    Tidsskr Nor Laegeforen; 1972 Aug; 92(23):1474-6. PubMed ID: 4404419
    [No Abstract]   [Full Text] [Related]  

  • 5. Anxiolytics not acting at the benzodiazepine receptor: beta blockers.
    Tyrer P
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):17-26. PubMed ID: 1348368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anxiolytic effects of beta-adrenoceptor blockers.
    Ogle CW
    Singapore Med J; 1976 Jun; 17(2):98-100. PubMed ID: 10631
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative electroencephalographic evaluation of anxiolytics afobazol and diazepam in MR and MNRA inbred rats with different anxiety levels].
    Kozhechkin SN
    Eksp Klin Farmakol; 2003; 66(2):38-41. PubMed ID: 12962046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
    Kozlovskiĭ VL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of anxiety between smokers and nonsmokers with acute myocardial infarction.
    Sheahan SL; Rayens MK; An K; Riegel B; McKinley S; Doering L; Garvin BJ; Moser DK
    Am J Crit Care; 2006 Nov; 15(6):617-25. PubMed ID: 17053270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The chronobiological characteristics of the antistressor action of anxiolytic agents].
    Arushanian EB; Beĭer EV
    Eksp Klin Farmakol; 1998; 61(6):13-6. PubMed ID: 9929809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of anxiety states].
    Laux G
    Krankenpfl J; 1982 Feb; 20(2):22-4. PubMed ID: 6121084
    [No Abstract]   [Full Text] [Related]  

  • 13. [Psychopharmacologic agents II. Anxiolytic agents. Benzodiazepine].
    Fisch HU
    Ther Umsch; 1982 Oct; 39(10):821-3. PubMed ID: 6130638
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of 2 hypnotics, flunitrazepam and triazolam, on sleeping. Psychometric evaluation and pharmacokinetic correlation].
    Fayat-Picard J; Gardes JP; Loustalan JM; Gayral LF
    Ann Med Psychol (Paris); 1984 May; 142(5):688-96. PubMed ID: 6150673
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
    Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B
    Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR; Merikangas JR
    Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psychophysiology of anxiety.
    Lader M
    Encephale; 1983; 9(4 Suppl 2):205B-210B. PubMed ID: 6144515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anxiety and the mechanisms of action of anxiolytics].
    Marino A; Costa R
    Recenti Prog Med; 1993 Feb; 84(2):129-41. PubMed ID: 8096650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRF antagonists Dupont.
    Preti A
    Curr Opin Investig Drugs; 2001 Feb; 2(2):274-9. PubMed ID: 11816844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.